Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


03.10.2022

1 Eur J Gastroenterol Hepatol
1 Hepatology
4 J Hepatol
2 J Med Virol
1 J Viral Hepat
1 J Virol
1 MMWR Morb Mortal Wkly Rep
1 PLoS One
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Eur J Gastroenterol Hepatol

  1. GARRIDO I, Liberal R, Peixoto A, Macedo G, et al
    "Long-term follow-up and prognosis of celiac hepatitis".
    Eur J Gastroenterol Hepatol. 2022 Sep 23. pii: 00042737-990000000-00077.
    PubMed         Abstract available


    Hepatology

  2. YIP TC, Wong VW, Wong GL
    Does hepatic steatosis impact chronic hepatitis B?
    Hepatology. 2022 Sep 24. doi: 10.1002/hep.32803.
    PubMed        


    J Hepatol

  3. CARSON JM, Barbieri S, Matthews GV, Dore GJ, et al
    National trends in retreatment of HCV due to reinfection or treatment failure in Australia.
    J Hepatol. 2022 Sep 21. pii: S0168-8278(22)03118.
    PubMed         Abstract available

  4. GILLICH N, Zhang Z, Binder M, Urban S, et al
    Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication.
    J Hepatol. 2022 Sep 21. pii: S0168-8278(22)03113.
    PubMed         Abstract available

  5. OLTMANNS C, Liu Z, Mischke J, Tauwaldt J, et al
    Reverse Inflammaging: Long-term effects of HCV cure on biological age.
    J Hepatol. 2022 Sep 21. pii: S0168-8278(22)03115.
    PubMed         Abstract available

  6. SUN L, Feng H, Misumi I, Shirasaki T, et al
    Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.
    J Hepatol. 2022 Sep 21. pii: S0168-8278(22)03120.
    PubMed         Abstract available


    J Med Virol

  7. LUO J, Liang X, Xin J, Li P, et al
    Serum ferritin diagnosis and prediction of hepatitis B virus-related acute-on-chronic liver failure.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28183.
    PubMed         Abstract available

  8. ADEBOYEJO K, King B, Tsoleridis T, Tarr A, et al
    Hepatitis C subtyping assay failure in UK patients born in Sub-Saharan Africa: implications for global treatment and elimination.
    J Med Virol. 2022 Sep 27. doi: 10.1002/jmv.28178.
    PubMed         Abstract available


    J Viral Hepat

  9. QIU LX, Huang Y, Quan JL, Bi ZF, et al
    The prognosis of hepatitis E infection in patients with chronic liver disease: a meta-analysis.
    J Viral Hepat. 2022 Sep 30. doi: 10.1111/jvh.13754.
    PubMed         Abstract available


    J Virol

  10. LIU Y, Kornyeyev D, May L, Han D, et al
    Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.
    J Virol. 2022;96:e0084922.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  11. FOSTER MA, Hofmeister MG, Yin S, Montgomery MP, et al
    Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1229-1234.
    PubMed         Abstract available


    PLoS One

  12. LEE AW, Jacobs W, Tran M, Nguyen B, et al
    Sociodemographic characteristics associated with hepatitis C virus infection in Vietnamese Americans: A cross-sectional analysis of community screening data.
    PLoS One. 2022;17:e0275210.
    PubMed         Abstract available


    Vaccine

  13. KUIPER VP, van der Plas P, Hoogerwerf MA, Pieter R Koopman J, et al
    A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease.
    Vaccine. 2022 Sep 22. pii: S0264-410X(22)01100.
    PubMed         Abstract available

  14. FENG T, Li M, Zhang L, Li S, et al
    Immunity of two novel hepatitis C virus polyepitope vaccines.
    Vaccine. 2022 Sep 20. pii: S0264-410X(22)01115.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: